Pediatrics
News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
News
Already-available drug could help treat type 1 diabetes
DFMO inhibits the polyamine biosynthesis pathway, which plays a role in the inflammatory responses in autoimmune diseases.
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
Conference Coverage
Alpha-gal syndrome: Red meat is ‘just the beginning,’ expert says
“We are seeing increasing diagnoses of AGS in places that are not, perhaps, where we first thought this allergy existed.”
News from the FDA/CDC
FDA to health care providers: Double-check COVID vaccine dose for children
“Parents were telling us of cases where pharmacies accidentally gave their children a double dose, while doctors in our group were pointing out...
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News
Systematic review spotlights the use of nutraceuticals for acne
Zinc was the most studied nutraceutical, but there was substantial heterogeneity in the results.
News
Adolescents with atopic dermatitis more likely to have experienced bullying, study finds
“Clinicians, families, and schools should address and monitor bullying among adolescents.”
Commentary
Upper respiratory infections: Viral testing in primary care
Test results will help guide not only treatment decisions but also infection control measures.
News
FDA approves fixed dose combination topical treatment for acne
The new treatment combines three approved acne products for once-daily use.